TransEnterix (NYSE:TRXC) said yesterday that it submitted an application for 510(k) clearance from the FDA for its SurgiBot robot-assisted surgery device. Research Triangle Park, N.C.-based TransEnterix claims the SurgiBot as the 1st patient-side robotically enhanced laparoscopy platform, designed to be wheeled to a patient’s bedside. "TransEnterix is pleased to deliver on our commitment to file […]
SafeStitch Medical takes TransEnterix’s name
Florida medical device maker SafeStitch Medical was reborn as TransEnterix Inc. as the companies navigated a previously announced merger.
SafeStitch shareholders approved a restated certificate of incorporation, under which the company took TransEnterix’s name more than tripled the number of authorized shares of common stock from 225 million to 750 million, according to regulatory documents.
SafeStitch lures Baxano CFO Slattery to be new finance chief
CORRECTION: SafeStitch Medical issues shares in TransEnterix merger
Correction, Sept. 17, 2013: Due to a reporter’s error, this article originally stated that SafeStitch raised $160 million. The company instead issued $160 million worth of shares as part of its merger with TransEnterix.
SafeStitch Medical to merge with TransEnterix, raise $30M
SafeStitch Medical (OTC:SFES) and TransEnterix are set to merge next quarter in a deal that includes a private placement worth about $30 million.
Medtech funding: SafeStitch Medical raises $3 million
SafeStitch Medical reported raising $3 million in a March 28, 2013, regulatory filing:
Company: SafeStitch Medical
Raise: $3 million
Security: Equity, Options & Warrants
Investors: 17
Sales Commission: $0
Finders’ Fees: $0
Amgen mourns death of founder George Rathmann | Personnel Moves
The Dow flirts with 13,000 | Wall Street Beat
The Dow Jones Industrial Average, a longtime bellwether for the U.S. economy, flirted yesterday with a high-water mark not seen since Lehman Brothers’ collapse triggered an economic implosion more than 4 years ago.
The Dow reached 13,005.04 at one point yesterday, before subsiding to close at 12,965.69 yesterday. It’s the first time the index has climbed that high since May 2008.
Investors were heartened by a deal struck in the European Union to resolve Greece’s debt crisis and by positive earnings results from a pair of American stalwarts.
MedGadget’s MedTech Monday: FDA approves the world’s most powerful CRT-D
FDA approves the world’s most powerful CRT-D: The Food & Drug Administration cleared Milan, Italy-based Sorin Group’s next-generation cardiac resynchronization therapy defibrillator, the Paradym CRT Model 8750. It’s the world’s most powerful CRT-D, according to the company, packing a 37-Joule punch. The company said it’s already been implanted in a first patient. 
MassDevice Network
@MassDevice
LinkedIn
YouTube